Log In
Print
BCIQ
Print
Print this Print this
 

RTA 801

  Manage Alerts
Collapse Summary General Information
Company Reata Pharmaceuticals Inc.
DescriptionOral superoxide dismutase 1 (SOD1) stabilizer
Molecular Target Superoxide dismutase 1 (SOD1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today